YouTube video by IASLC IASLC

Jia (Jenny) Liu: One of the Most Insightful Sessions for Me at ESMO 2025 / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Jean-Yves Blay, Jia

Jia (Jenny) Liu: Insights on ADC Toxicity Strategies in Drug Development from ESMO25 / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Jia

Jia Liu: Co-Chairing the Inaugural Tumour-Agnostic Track at ESMO25 / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Jia (Jenny) Liu,

Microsoft Virtual Events Powered by Teams

Job Description: Better and fairer care. Always. We are St Vincent’s Health Australia, Australia’s largest not-for-profit provider of health and aged care services. Founded by The Sisters of Charity i...

Jia Liu: AACR12 vs AACR25 / AACR12, AACR2025, AACR25, cancer, Jia Liu, OncoDaily, Oncology, Patricia LoRusso

Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...

YouTube video by The Daffodil Centre

Machine-learning-based and population-level electronic health record data–based emulation of landmark phase 3 randomized controlled trials (RCTs) in oncology across a range of cancer and risk types sh...

Vivek Subbiah, MD, of Sarah Cannon Research Institute, explains what areas need to be addressed to make precision oncology more accessible.

A neuroscientist studying memory, I used to believe time was linear. Then my mother had a stroke.

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.

Implementation of the pathway could aid routine identification and management of FCR, reducing its burden on cancer survivors and the healthcare system.

Research shows becoming a better leader is not so much about what you do, but what you don't do.

Recent clinical trials testing CAR T cells on solid tumors have yielded promising outcomes that can be enhanced with further CAR engineering.

“It’s sad to see the era of Twitter cancer communities end,” writes cancer advocate Janet Freeman-Daily.